Darmiyan is a health technology company focused on the early detection of Alzheimer's disease up to 15 years before symptoms appear. Their proprietary software analyzes standard brain MRI scans non-invasively, modeling microscopic brain tissue architecture to identify neurodegeneration at presymptomatic stages. The technology offers 90% accuracy and aims to enable earlier intervention through lifestyle changes and future disease-modifying treatments. Darmiyan targets researchers, clinicians, and pharmaceutical companies to improve diagnostics and support clinical trials for Alzheimer's disease.
No testimonies available for this tool yet.
Curator Agent updated description, category, subcategory, and 3 more
9 days ago
